Massachusetts Financial Services
FOLD

Massachusetts Financial Services’s Amicus Therapeutics FOLD Stock Holding History

Massachusetts Financial Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125,524
Closed -$1.79M – 963
2025
Q4 		$1.79M Sell
125,524
-3,583,214
-97% -$35.2M ﹤0.01% 799
2025
Q3 		$29.2M Sell
3,708,738
-17,730
-0.5% -$126K 0.01% 574
2025
Q2 		$21.4M Buy
3,726,468
+450,097
+14% +$2.9M 0.01% 608
2025
Q1 		$26.7M Buy
3,276,371
+8,996
+0.3% +$83.2K 0.01% 563
2024
Q4 		$30.8M Buy
3,267,375
+107,348
+3% +$1.12M 0.01% 540
2024
Q3 		$33.7M Buy
3,160,027
+139,491
+5% +$1.52M 0.01% 520
2024
Q2 		$30M Buy
3,020,536
+378,999
+14% +$3.89M 0.01% 530
2024
Q1 		$31.1M Buy
2,641,537
+226,447
+9% +$2.9M 0.01% 525
2023
Q4 		$34.3M Buy
2,415,090
+593,131
+33% +$6.73M 0.01% 510
2023
Q3 		$22.2M Buy
1,821,959
+340,673
+23% +$4.39M 0.01% 551
2023
Q2 		$18.6M Buy
+1,481,286
New +$17.6M 0.01% 564
2021
Q4 		– Sell
-886,513
Closed -$8.47M – 907
2021
Q3 		$8.47M Sell
886,513
-370,048
-29% -$3.79M ﹤0.01% 678
2021
Q2 		$12.1M Sell
1,256,561
-3,595
-0.3% -$35.1K ﹤0.01% 656
2021
Q1 		$12.4M Buy
1,260,156
+80,472
+7% +$1.25M ﹤0.01% 648
2020
Q4 		$27.2M Sell
1,179,684
-721,907
-38% -$14.8M 0.01% 561
2020
Q3 		$26.9M Sell
1,901,591
-23,056
-1% -$336K 0.01% 531
2020
Q2 		$29M Buy
1,924,647
+145,456
+8% +$1.77M 0.01% 503
2020
Q1 		$16.4M Buy
1,779,191
+214,466
+14% +$2.04M 0.01% 541
2019
Q4 		$15.2M Buy
1,564,725
+170,062
+12% +$1.56M 0.01% 562
2019
Q3 		$11.2M Buy
1,394,663
+263,719
+23% +$2.86M ﹤0.01% 598
2019
Q2 		$14.1M Buy
1,130,944
+112,845
+11% +$1.43M 0.01% 587
2019
Q1 		$13.8M Buy
1,018,099
+20,517
+2% +$251K 0.01% 579
2018
Q4 		$9.56M Buy
997,582
+21,012
+2% +$231K ﹤0.01% 603
2018
Q3 		$11.8M Buy
976,570
+200,340
+26% +$2.8M ﹤0.01% 602
2018
Q2 		$12.1M Buy
776,230
+10,809
+1% +$163K 0.01% 604
2018
Q1 		$11.5M Buy
765,421
+80,306
+12% +$1.22M ﹤0.01% 591
2017
Q4 		$9.86M Buy
685,115
+8,998
+1% +$124K ﹤0.01% 619
2017
Q3 		$10.2M Sell
676,117
-307,659
-31% -$4.07M ﹤0.01% 603
2017
Q2 		$9.91M Sell
983,776
-205
-0% -$1.65K ﹤0.01% 604
2017
Q1 		$7.02M Sell
983,981
-1,523
-0.2% -$9.63K ﹤0.01% 626
2016
Q4 		$4.9M Buy
985,504
+282,132
+40% +$1.95M ﹤0.01% 668
2016
Q3 		$5.21M Buy
703,372
+11,713
+2% +$79.1K ﹤0.01% 645
2016
Q2 		$3.78M Sell
691,659
-23,318
-3% -$163K ﹤0.01% 670
2016
Q1 		$6.04M Buy
714,977
+8,932
+1% +$63.3K ﹤0.01% 621
2015
Q4 		$6.85M Sell
706,045
-4,908
-0.7% -$44.2K ﹤0.01% 620
2015
Q3 		$9.95M Sell
710,953
-300,586
-30% -$4.71M 0.01% 597
2015
Q2 		$14.3M Sell
1,011,539
-134,967
-12% -$1.62M 0.01% 570
2015
Q1 		$12.5M Buy
1,146,506
+32,179
+3% +$284K 0.01% 603
2014
Q4 		$9.27M Buy
+1,114,327
New +$7.65M ﹤0.01% 625

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Massachusetts Financial Services's FOLD Position: Q1 2026 in Review

Massachusetts Financial Services sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 125,524 shares — an estimated $1.79M sold.

Massachusetts Financial Services first reported a position in FOLD in Q4 2014 and held it in 39 quarters. The position peaked at $34.3M in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Massachusetts Financial Services reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 125,524 Amicus Therapeutics shares in Q1 2026, an estimated $1.79M.
  • Massachusetts Financial Services first reported a position in Amicus Therapeutics in Q4 2014 and held it in 39 quarters.
  • Massachusetts Financial Services's Amicus Therapeutics position peaked at $34.3M in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.